Cargando…

Recombinant immunotoxin induces tumor intrinsic STING signaling against head and neck squamous cell carcinoma

The innate immune stimulator of interferon genes (STING) pathway is known to activate type I interferons (IFN-I) and participate in generating antitumor immunity. We previously produced hDT806, a recombinant diphtheria immunotoxin, and demonstrated its efficacy against head and neck squamous cell ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Guiqin, Shan, Liang, Yang, Cuicui, Liu, Yuanyi, Pang, Xiaowu, Teng, Shaolei, Wu, Tzyy-Choou, Gu, Xinbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613212/ https://www.ncbi.nlm.nih.gov/pubmed/37898690 http://dx.doi.org/10.1038/s41598-023-45797-7

Ejemplares similares

Antitumor Efficacy of EGFR-Targeted Recombinant Immunotoxin in Human Head and Neck Squamous Cell Carcinoma
por: Xie, Guiqin, et al.
Publicado: (2022)

Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges
por: Zhu, Shaowei, et al.
Publicado: (2017)

Evaluation of Vertebrate-Specific Replication-Defective Zika Virus, a Novel Single-Cycle Arbovirus Vaccine, in a Mouse Model
por: Wan, Shengfeng, et al.
Publicado: (2021)

Functions of MiRNA-128 on the Regulation of Head and Neck Squamous Cell Carcinoma Growth and Apoptosis
por: Hauser, Belinda, et al.
Publicado: (2015)

MiR-124 acts as a tumor suppressor by inhibiting the expression of sphingosine kinase 1 and its downstream signaling in head and neck squamous cell carcinoma
por: Zhao, Yuan, et al.
Publicado: (2017)

Clinical targeting recombinant immunotoxins for cancer therapy
por: Li, Meng, et al.
Publicado: (2017)

Mesothelin-Targeted Recombinant Immunotoxins for Solid Tumors
por: Hagerty, Brendan L., et al.
Publicado: (2020)

Development of Recombinant Immunotoxins for Hairy Cell Leukemia
por: Kreitman, Robert J., et al.
Publicado: (2020)

Evaluation of Hydra HALT-1 as a toxin moiety for recombinant immunotoxin
por: Jiemy, William F., et al.
Publicado: (2020)

Salvianolic Acid B, a Potential Chemopreventive Agent, for Head and Neck Squamous Cell Cancer
por: Zhao, Yuan, et al.
Publicado: (2011)

Hosts for Hostile Protein Production: The Challenge of Recombinant Immunotoxin Expression
por: Zuppone, Stefania, et al.
Publicado: (2019)

In vivo solid tumor targeting with recombinant VEGF-diphtheria immunotoxin
por: Hosseininejad-Chafi, Mohammad, et al.
Publicado: (2022)

Immunotoxin-Induced Ablation of the Intrinsically Photosensitive Retinal Ganglion Cells in Rhesus Monkeys
por: Ostrin, Lisa A., et al.
Publicado: (2018)

Construction, Expression, and Characterization of a Recombinant Immunotoxin Targeting EpCAM
por: Lv, Minghua, et al.
Publicado: (2015)

Recombinant immunotoxins development for HER2-based targeted cancer therapies
por: Mahmoudi, Reza, et al.
Publicado: (2021)

Evaluating the influence of common antibiotics on the efficacy of a recombinant immunotoxin in tissue culture
por: Zhu, Yuyi, et al.
Publicado: (2019)

Strategies to mitigate the on- and off-target toxicities of recombinant immunotoxins: an antibody engineering perspective
por: Li, Mengyu, et al.
Publicado: (2022)

Antitumor properties of Salvianolic acid B against triple-negative and hormone receptor-positive breast cancer cells via ceramide-mediated apoptosis
por: Sha, Wei, et al.
Publicado: (2018)

Immunotoxins: experimental design
por: Dall, P, et al.
Publicado: (2001)

Immunotoxins: The Role of the Toxin (†)
por: Antignani, Antonella, et al.
Publicado: (2013)

Countering immunotoxin immunogenicity
por: Flavell, David J
Publicado: (2016)

Intrinsic Oncogenic Function of Intracellular Connexin26 Protein in Head and Neck Squamous Cell Carcinoma Cells
por: Iikawa, Nobuko, et al.
Publicado: (2018)

Integrating Intrinsic Radiosensitivity and Immune Status for Predicting Benefits of Radiotherapy in Head and Neck Squamous Cell Carcinoma
por: Sun, Chuyao, et al.
Publicado: (2021)

Interactions Between Pseudomonas Immunotoxins and the Plasma Membrane: Implications for CAT-8015 Immunotoxin Therapy
por: Bokori-Brown, Monika, et al.
Publicado: (2018)

SMYD3 represses tumor-intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neck
por: Nigam, Nupur, et al.
Publicado: (2023)

Treatment of solid tumors with immunotoxins
por: Messmer, Davorka, et al.
Publicado: (2005)

Bouganin, an Attractive Weapon for Immunotoxins
por: Bortolotti, Massimo, et al.
Publicado: (2018)

Immunotoxin Therapy for Lung Cancer
por: Xie, Li-Yi, et al.
Publicado: (2017)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes
por: Cerboni, Silvia, et al.
Publicado: (2017)

Design, characterization and anti-tumour cytotoxicity of a panel of recombinant, mammalian ribonuclease-based immunotoxins.
por: Deonarain, M. P., et al.
Publicado: (1998)

Novel Therapy for Atherosclerosis Using Recombinant Immunotoxin Against Folate Receptor β–Expressing Macrophages
por: Furusho, Yuko, et al.
Publicado: (2012)

Quantification of recombinant immunotoxin delivery to solid tumors allows for direct comparison of in vivo and in vitro results
por: Mason-Osann, Emily, et al.
Publicado: (2015)

Dual B- and T-cell de-immunization of recombinant immunotoxin targeting mesothelin with high cytotoxic activity
por: Mazor, Ronit, et al.
Publicado: (2016)

Novel recombinant immunotoxin of EGFR specific nanobody fused with cucurmosin, construction and antitumor efficiency in vitro
por: Deng, Cuimin, et al.
Publicado: (2017)

Risk Factors for Esophageal Squamous Cell Carcinoma in Patients with Head and Neck Squamous Cell Carcinoma
por: Wang, Lei, et al.
Publicado: (2022)

Characteristics of esophageal cancer in patients with head and neck squamous cell carcinoma
por: Wang, Lei, et al.
Publicado: (2021)

Mining TCGA database for prognostic genes in head and neck squamous cell carcinoma microenvironment
por: Ran, Qiu-Chi, et al.
Publicado: (2021)

Cytotoxins and immunotoxins for cancer therapy : clinical applications /
Publicado: (2005)

Pharmacokinetic studies in mice with ICI D0490, a novel recombinant ricin A-chain immunotoxin.
por: Calvete, J. A., et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_vm8o9r67n96brdjo3ehvh2f4av